Package 51655-201-52

Brand: amlodipine besylate and benazepril hydrochloride

Generic: amlodipine besylate and benazepril hydrochloride
NDC Package

Package Facts

Identity

Package NDC 51655-201-52
Digits Only 5165520152
Product NDC 51655-201
Description

30 CAPSULE in 1 BOTTLE, PLASTIC (51655-201-52)

Marketing

Marketing Status
Marketed Since 2023-04-19
Brand amlodipine besylate and benazepril hydrochloride
Generic amlodipine besylate and benazepril hydrochloride
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "48c439c7-5726-89ae-e063-6394a90a41f6", "openfda": {"unii": ["864V2Q084H", "N1SN99T69T"], "rxcui": ["898356"], "spl_set_id": ["fa153720-b24c-60d0-e053-6294a90a97d5"], "manufacturer_name": ["Northwind Health Company, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE in 1 BOTTLE, PLASTIC (51655-201-52)", "package_ndc": "51655-201-52", "marketing_start_date": "20230419"}], "brand_name": "Amlodipine Besylate and Benazepril Hydrochloride", "product_id": "51655-201_48c439c7-5726-89ae-e063-6394a90a41f6", "dosage_form": "CAPSULE", "pharm_class": ["Angiotensin Converting Enzyme Inhibitor [EPC]", "Angiotensin-converting Enzyme Inhibitors [MoA]", "Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Decreased Blood Pressure [PE]", "Dihydropyridine Calcium Channel Blocker [EPC]", "Dihydropyridines [CS]"], "product_ndc": "51655-201", "generic_name": "Amlodipine Besylate and Benazepril Hydrochloride", "labeler_name": "Northwind Health Company, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Amlodipine Besylate and Benazepril Hydrochloride", "active_ingredients": [{"name": "AMLODIPINE BESYLATE", "strength": "5 mg/1"}, {"name": "BENAZEPRIL HYDROCHLORIDE", "strength": "20 mg/1"}], "application_number": "ANDA077183", "marketing_category": "ANDA", "marketing_start_date": "20230419", "listing_expiration_date": "20271231"}